Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.66 USD
Change Today +0.0162 / 2.52%
Volume 67.3K
BGMD On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 05/26/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for bg medicine inc (BGMD)

Year over year, BG Medicine, Inc. has seen revenues shrink from $4.1M USD to $2.8M USD, though the company was able to grow net income from a loss of $15.8M USD to a smaller loss of $8.1M USD. A reduction in the percentage of sales devoted to selling, general and administrative costs from 327.11% to 234.09% was a key component in the bottom line growth in the face of falling revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Dec 31
2012
Reclassified
Dec 31
2013
Dec 31
2014
4 Year
Trend
Revenues1.62.84.12.8
TOTAL REVENUES1.62.84.12.8
Cost of Goods Sold0.61.01.41.0
GROSS PROFIT1.01.92.71.8
Selling General & Admin Expenses, Total10.517.013.36.5
R&D Expenses8.07.63.72.3
OTHER OPERATING EXPENSES, TOTAL18.524.617.18.8
OPERATING INCOME-17.5-22.7-14.4-7.0
Interest Expense-0.1-1.1-1.2-0.7
Interest and Investment Income0.00.00.00.0
NET INTEREST EXPENSE-0.1-1.1-1.2-0.7
Other Non-Operating Income (Expenses)0.00.0-0.30.0
EBT, EXCLUDING UNUSUAL ITEMS-17.6-23.8-15.8-7.7
Merger & Restructuring Charges-------0.4
EBT, INCLUDING UNUSUAL ITEMS-17.6-23.8-15.8-8.1
Earnings from Continuing Operations-17.6-23.8-15.8-8.1
NET INCOME-17.6-23.8-15.8-8.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-17.7-23.8-15.8-8.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-17.7-23.8-15.8-8.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BGMD:US $0.66 USD +0.0162

BGMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $51.03 USD -0.27
Bio-Reference Laboratories Inc $32.74 USD -0.61
BioMerieux €101.60 EUR -0.30
Laboratory Corp of America Holdings $119.82 USD -1.60
Quest Diagnostics Inc $77.38 USD -2.22
View Industry Companies
 

Industry Analysis

BGMD

Industry Average

Valuation BGMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.9x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BG MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.